跳至主要内容
临床试验/NCT05935930
NCT05935930已完成4 期

Postoperative Effects of Propofol Versus Sevoflurane Anesthesia During Elective Non-Cardiac Surgeries. A Randomized Clinical Trial

Damanhour Teaching Hospital1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2021年12月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
44
试验地点
1
主要终点
Mean and Standard deviation of Neuron Specific Enolase enzyme (µg/L) in blood serum (mean±SD)

研究概览

简要总结

Background: The choice of appropriate anesthetics is essential to protect brain function, decrease perioperative complications, and provide high-quality care, and better quality of life.

Objectives: To compare the efficacy and safety of propofol versus sevoflurane in patients undergoing elective, non-cardiac operations under general anesthesia.

Methods: This was a randomized (1:1), parallel, phase four clinical trial; carried out on 44 patients, who were candidates for elective, non-cardiac operations under general anesthesia at our hospital. Patients were randomly allocated into two equal groups in which anesthesia was maintained with propofol infusion in group P and sevoflurane inhalation in group S.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status ≤ II
  • Age from 21 years
  • Body Mass Index (BMI) 25-35 kg/m2

排除标准

  • ASA physical status > II
  • Age < 21 years
  • Patients with Montreal Objective Cognitive Assessment (MoCA-B) score < 24 points
  • Patients with significant cardiovascular, cerebrovascular, respiratory, liver, renal, endocrine, blood, or immune diseases
  • Patients with visual or auditory disease, infection, chronic inflammation, disturbance of consciousness, cognitive impairment, or dementia
  • Patients on long-term use of sedatives or steroids, alcohol or drug abuse
  • Allergy to any of the study drugs

研究组 & 干预措施

Group P (n=22)

Active Comparator

Propofol group

干预措施: Propofol 10 MG/ML Injection (Drug)

Group S (n=22)

Active Comparator

Sevoflurane group

干预措施: Sevoflurane Inhalation Liquid (Drug)

结局指标

主要结局

Mean and Standard deviation of Neuron Specific Enolase enzyme (µg/L) in blood serum (mean±SD)

时间窗: 24 hours after the end of operation

Before operation (T0), 1 hour after the end of operation (T1), 24 hours the end of operation (T2)

次要结局

未报告次要终点

研究者

发起方
Damanhour Teaching Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验